Today we proudly welcome Ekolab into the Conscio Group. This strategic partnership enhances our analytical capabilities and solidifies our position as a provider of comprehensive solutions in the Pharmaceutical, Nutrition, and Technology sectors.

Ekolab, a laboratory based in Košice, Slovakia, and founded in 1992, has established a long-term reputation as a customer-focused and high-quality company, with expertise in physicochemical, microbiological, and biological analyses for a range of target industries. Over the years, Ekolab has stayed at the forefront of evolving legislation, meeting customer needs and processing diverse analytes from various sectors: Food & feed, environmental, industrial, health and pharmacy.

Stephan Holl, CEO Conscio Group commented: “We are excited about this partnership as it highlights our commitment to delivering excellent science to our valued clients. As the 6th member of the Conscio Group, Ekolab brings a wealth of experience, knowledge, and state-of-the-art facilities to our organization. Together, we now can further expand our offering and foster innovation across our fast-growing network.

About Ekolab s.r.o.: EKOLAB is a renowned testing laboratory with a wide range of expertise in physicochemical, microbiological, and biological analyses. Ekolab specializes in the analysis of environmental samples, food & feed, health and pharmacy, fuels, and industrial products. Established in 1992 and based in Košice, Slovakia, Ekolab is committed to quality and safety across industries.

About the Conscio Group: Conscio Group is a network of quality science organizations committed to ensuring good health for all by improving the safety and reliability of food and pharmaceuticals. Conscio members include LVA (Austria), EL Labs (Slovakia), HyServe (Germany), Quinta-Analytica (Czechia), Gen-Plus (Germany) and Ekolab (Slovakia).

Contact:
Conscio Holding GmbH: info@consciogroup.com
Ekolab s.r.o.: info@ekolab.sk

Giving back to our local community in Munich is important to everyone at BBA, which is why the entire team spent a Social Day at the Münchner Tafel e.V.. After a warm welcome by the staff and fellow volunteers as well as a short briefing on the activities, we started with our work. Our main task was to sort the food that was delivered by trucks and then hand it out to the families in need at various stations across Munich. It was incredibly fulfilling to see how grateful people have been for our help. 

The day showed us how important it is to open our eyes to the needs of the people around us. It left a deep and lasting impression on the whole team, and we are grateful for the opportunity to help others with such an immediate impact. We will definitely continue to help improve the lives of those in need in our city in the future!

Münchner Tafel e.V. supports more than 23,000 people per week at 28 food serving points with more than 800 volunteers. What impressive numbers! 

If you got inspired now and would like to support a similiar initiative, reach out to Münchner Tafel e.V.. They are grateful for any support! 

Contact:

Münchner Tafel e.V. 
info@muenchen-tafel.de

Münchner Tafel e.V., Schäftlarnstraße 10, 81371 Munich
www.muenchner-tafel.com

Gen-Plus GmbH & Co. KG (“Gen-Plus”) has decided to join forces with Conscio Holding GmbH (“Conscio Group”), an independent international network of scientific services providers. The partnership strengthens Conscio’s innovation capabilities and allows Conscio to provide an optimal service offering to its customers. Jointly, Gen-Plus and the Conscio Group will be able to support their customers in developing innovative products for end-consumers and patients. 

Dr. Dachtler, Managing Director of Gen-Plus, explains: “By joining forces with the Conscio Group, we can provide a truly unique ‘end-to-end’ service offering to small and large pharmaceutical customers, from idea to commercialization. Gen-Plus supports the product idea generation, active ingredient screening, formulation work, and GMP-production. Conscio adds in house clinical trials, bioanalytical testing, extensive pharmaceutical testing, etc. I believe Conscio is the perfect partner for Gen-Plus’ next phase of growth. Our service portfolios are highly complementary, we share culture and values, and our continued independence is guaranteed.” Dr. Dachtler will remain Managing Director of Gen-Plus and joins the Executive Committee of the Conscio Group.

Dr. Wolfhart Hauser, Chairman of the Advisory Board of the Conscio Group added: “Gen-Plus offers unique technology and innovation capabilities through its extensive project experience. The continuous investment into new capabilities enables Gen-Plus to develop better medication for patients. The Company’s relentless focus on its customers, agile working mode, and scientific work of the highest quality has impressed us and is aligned with Conscio Group’s own values. We look forward to partnering with Dr. Dachtler and the entire Gen-Plus team to grow and develop the organization.“ 

About Gen-Plus GmbH & Co. KG (“Gen-Plus”): Gen-Plus is an R&D and manufacturing expert for the pharmaceutical industry, from proof-of-concept to clinical trial samples and small batch GMP production. It has extensive experience in the key technologies of patches and thin films, 2D and 3D printing of drugs, high potent drugs and narcotics, hot melt extrusion, and tailored release profiles. Founded in 1999 and acquired in 2015 by Dr. Markus Dachtler (Managing Director), Gen-Plus has 25 highly qualified employees and is headquartered in Munich, Germany.

About the Conscio Holding GmbH (“Conscio Group”): Conscio Group is an independent international network of quality science organizations committed to ensuring good health for all by improving the safety and reliability of food and pharmaceuticals. The Conscio Group is a fully certified provider of pharmaceutical analysis, bioanalytical testing, analytical R&D, clinical studies, biopharma analyses, QC analyses, batch release, and IMPD compilation. The pharmaceutical activities of the Conscio Group include Quinta-Analytica s.r.o. (Prague, Czech Republic), EL spol. s.r.o (Spišská Nová Ves, Slovakia), and LVA GmbH (Klosterneuburg, Austria). 

The Conscio Group is backed by BBA Capital Partners, an independent owner-financed investment group. BBA is guided by its Family Equity philosophy, combining the long-term mindset of a family business with sustainable and professional corporate development. 

Contact:

Conscio Holding GmbH 
info@consciogroup.com

Gen-Plus GmbH & Co KG, Staffelseestraße 6, 81477 Munich
www.gen-plus-e.com

“Quinta-Analytica is a leading independent partner for pharmaceutical companies, ensuring pharmaceutical drugs are safely and rapidly brought to those who need them. The Company’s focus on its customers, high quality, scientific excellence, and flexibility differentiates it in the market. We are excited to partner with its top management team and employees to continue to be a reliable partner to Quinta-Analytica’s customers as well as to sustainably and responsibly develop the Company to the benefit of end-consumers,” explains Felix Burgdorf, Managing Director and co-owner of BBA. 

Quinta-Analytica s.r.o. provides a broad range of services including analytical testing, clinical studies, and R&D to its global customer base. Founded in 1996, Quinta-Analytica has more than 200 employees and is headquartered in Prague, Czech Republic. 

Roman Grunt, CEO of Quinta-Analytica, added: “This move is another step for Quinta-Analytica and its employees on our growth path. Today we have a chance to not only keep Quinta-Analytica’s essence, but with the network and financial support of our new partner we will grow further and play a leading role in building BBA’s pharma services activities.“ 

About BBA: BBA Capital Partners is an owner-managed and owner-financed investment company that offers medium-sized market leaders long-term entrepreneurial capital. In the “Family Equity” philosophy, BBA combines the long-term, strategic mindset of a family company with sustainable and professional corporate development.

Contact:

BBA CapitalPartners:
info@bba-partners.com

Quinta-Analytica s.r.o., Pražská 1486/18c, 102 00 Prague 10 
www.quinta.cz

“Thanks to its scientific expertise, unique customer focus and a comprehensive range of services, LVA has in recent years developed into a market leader in laboratory analysis, especially in the area of food safety. We are therefore very pleased to work together with Dr. Gartner and the entire LVA team. It is in line with our mission statement ,Responsibility over Generations’, to continue to develop this excellent position of LVA sustainably and in the interests of our customers,” explains Felix Burgdorf, Managing Director and co-owner of BBA.

LVA GmbH is the leading private service provider for analysis and expertise in all aspects of food safety and quality. LVA stands for “Lebensmittel, Vertrauen, Analysen“ (“food, confidence, analysis”) through competent services in the areas of laboratory analysis, inspection, certification and consulting. Founded in 1927, LVA has around 130 employees and looks after over 7,000 customers in Austria and abroad.

Dr. Michael Gartner, Managing Director of LVA, who will stay in his position as CEO: “LVA can look back on a long tradition of highest quality, motivated employees and pronounced customer orientation. We are therefore particularly pleased that we have found a strong partner. With BBA Capital Partners, the long-term investment company, we can shape the future of LVA as an independent service provider. Our common objective is to continue to support our customers in producing and delivering food of the highest quality.”

About BBA: BBA Capital Partners is an owner-managed and owner-financed investment company that offers medium-sized market leaders long-term entrepreneurial capital. In the “Family Equity” philosophy, BBA combines the long-term, strategic mindset of a family company with sustainable and professional corporate development.

Contact:

BBA CapitalPartners:
info@bba-partners.com

LVA GmbH, Magdeburggasse 10, 3400 Klosterneuburg
www.lva.at